A venture capital firm that looks for and invests in talented entrepreneurs pushing humanity forward with innovation, providing capital, mentorship, and access to global connections.

Pier 70 Ventures

At Pier 70, we invest in impact-driven innovation. We find and fund disruptive technologies with the potential to shake up the status quo in healthcare. Entrepreneurs choose Pier 70 for capital and counsel, and we help them build diverse teams well-positioned to achieve financial success. Our success will be measured by their success and the collective value that we create.

Pier 70 Ventures advisor, Dennis Liotta, brilliant innovator, humanitarian and visionary leader in the field of drug discovery keynotes this fall.

Pier 70 Ventures portco, Acclinate receives the Blue Knight award from Johnson & Johnson and Biomedical Advanced Research and Development Authority (BARDA). Congratulations to Del Smith, PhD, Tiffany Whitlow and the Team.

https://lnkd.in/gRg5D45R

Pier 70 Ventures Managing Partner, R. Miller Adams delivers the keynote at Venture Mechanics Startup Incubator / Accelerator event, Black in Tech Venture Conference.   Keynote will be followed by a panel with Aina A., Madin Akpo-Esambe, Sarah Studer, and moderated by Evan Poncelet.

Pier 70 celebrates the continued success of our portfolio company, Acclinate, and the team’s successful completion of a $7 million Series A round. “This is an important mile marker in their journey to success, because it validates their thesis, their vision and most of all, their ability to execute flawlessly as a team. Del and Tiffany have maintained a culture of camaraderie and excellence in a growing team, while establishing themselves in a nascent market and are now regarded as the leaders in bringing equity to clinical trials." Says Preetha Ram, Managing Partner.

Shaun Hawkins, Managing Partner adds, “Establishing trust with large pharmaceutical companies is an art and a science, particularly when it relates to clinical trials. Acclinate’s attention to customer and community needs along with the manner in which they execute have led multiple partnerships with Big Pharma. We look forward to participating in Acclinate’s continued growth. We’re confident that the addition of strategic investors, Cencora and Labcorp will serve to accelerate that growth.”  
https://lnkd.in/gGGjiHrt
#healthequity #venturecapital #futureofhealth #diversityiclinicaltrials #aiforhealth

Good way to start the weekend by celebrating with the Acclinate team and my colleague and co-lead, Shaun Hawkins, as founders, Del and Tiffany close their next round.  Bringing diversity to clinical trials is tough, but they are leading the way!

Managing Partner Preetha Ram to moderate a panel on AI in Healthcare at #tiecon2024! If you are attending the conference, we'd love for you to meet her.
R. Miller Adams Shaun Hawkins Robert (Bob) Balk Minnie Sarwal Jenn Bennett Courtney L. Biolocity Paul Grewal Fatima Cody Stanford

IPhone / Mobile Compatible

Viewport Meta

SSL by Default

Google Font API

DNSSEC

Microsoft Exchange Online

Office 365 Mail

Google

GStatic Google Static Content

Co-Founder, Senior Managing Director

Robert (Bob) Balk

Senior Managing Director & General Partner, INpact Fund

Preetha Ram

Venture Partner

Frederick Grimm

Leland Melvin

Banking and Wealth Management

Shaun Hawkins

Finance and Administration

Theresa Rivkin

Managing Partner

Seed Stage Investors with Investments in Indiana

Early Stage Venture Investors with Investments in California (Top 10K)

Early Stage Venture Investors with Investments in New Jersey

Venture Stage Investors with Investments in Great Lakes

Pier 70 Ventures fund disruptive technologies with the potential to shake up the status quo in healthcare.

Seattle

Washington

United States

North America

India

Asia

Pakistan

news_impact_assignment_basic

key_people

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

merger_acquisitions

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	Jul 18, 2024 8:09 AM	7ef858ca
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general
crunchbase trigger	general	Oct 28, 2024 1:50 PM	078f0119
crunchbase profile	general	Oct 29, 2024 9:01 AM	2a15738f
li profile	general	Jul 18, 2024 8:09 AM	1c7097ee
translate crunchbase fundingrounds	general	Nov 6, 2024 3:12 PM	4a1250af
peers	general	Jul 18, 2024 8:09 AM	460ef53a
news basic	general	Jul 18, 2024 8:09 AM	b26b1d29
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

COM:PIER70VENTURES

Pier 70 Ventures